Cancer Immunology Immunotherapy
Last updated ISSN 0340-7004
Cancer Immunology Immunotherapy is published by Springer Science+Business Media in immunology and microbiology. It is open access. The article processing charge is $4,590.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Cancer Immunology Immunotherapy is — and show you journals like it.
What it publishes
Recent work in Cancer Immunology Immunotherapy concentrates on these topics, taken from its published record rather than from its own description:
- Immunotherapy and Immune Responses
- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
- CAR-T cell therapy research
- T-cell and B-cell Immunology
- Monoclonal and Polyclonal Antibodies Research
- Immune cells in cancer
- Glycosylation and Glycoproteins Research
- Immune Response and Inflammation
- Virus-based gene therapy research
Key facts
| Publisher | Springer Science+Business Media |
|---|---|
| ISSN | 0340-7004, 1432-0851 |
| Subject area | Immunology and Microbiology |
| Access | Open access |
| Article processing charge | $4,590 |
| Indexed in | Web of Science — Science Citation Index Expanded · Scopus · DOAJ |
| Articles published | 7,708 |
| Publishing since | 1976 |
| Journal website | www.springer.com/medicine/oncology/journal/262 |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Cancer Immunology Immunotherapy
Other established journals in immunology and microbiology, if this one is not the right home for your paper: